Navidea Biopharmaceuticals Inc (NAVB) stock has gained 99.23% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives NAVB stock a score of 92 out of a possible 100.
That rank is chiefly influenced by a long-term technical score of 96. NAVB's rank also includes a short-term technical score of 94. The fundamental score for NAVB is 85. In addition to the average rating from Wall Street analysts, NAVB stock has a mean target price of 5. This means analysts expect the stock to climb 93.05% over the next 12 months.
What's Happening with NAVB Stock Today
Navidea Biopharmaceuticals Inc (NAVB) stock is higher by 1.17% while the S&P 500 has fallen -0.31% as of 2:24 PM on Friday, May 29. NAVB has gained $0.03 from the previous closing price of $2.56 on volume of 409,571 shares. Over the past year the S&P 500 is up 8.30% while NAVB has gained 99.23%. NAVB lost -$0.69 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Navidea Biopharmaceuticals Inc (NAVB) Stock.
